During the COVID-19 pandemic, a chilling epidemiological term entered public conversation: superspreading. One person, in the right place at the right time, could infect dozens. Now researchers are applying that same lens to tuberculosis—a disease that has quietly killed millions and, they argue, holds a critical secret to stopping it.
Tuberculosis transmission has always been mysterious. Most people infected with Mycobacterium tuberculosis cause few secondary infections, sometimes none at all. But groundbreaking studies in the 1950s and 1960s revealed something counterintuitive: some TB patients are explosively infectious, triggering chains of transmission far beyond the norm. The gap between these patterns—between the quiet spreader and the superspreader—is where public health opportunity lives.
Researchers from Boston University Chobanian & Avedisian School of Medicine and the University of Colorado Anschutz School of Medicine have now crystallized this observation into a framework. In a perspective piece published in The Lancet Infectious Diseases, they introduce the concept of "superspreading niches"—specific pockets within community contact networks where highly infectious individuals meet highly susceptible people. It's not random. It's geography, social connection, and biology converging in particular places.
"We propose that identifying superspreading niche characteristics could allow for novel interventions directed at disrupting transmission early between highly infectious source cases and their susceptible contacts," explains Karen Jacobson, MD, MPH, an associate professor of medicine at Boston University and medical director of the Boston Medical Center Tuberculosis Clinic. The implications ripple outward: if you can identify these niches and intervene precisely, you don't have to treat everyone. You target the moment and place where transmission is most likely to accelerate.
What makes this framework more than academic speculation is TB's particular biology. Unlike rapidly spreading respiratory viruses, tuberculosis is a slowly progressive disease, offering a wider window for intervention. Someone diagnosed with TB who begins antibiotic therapy typically becomes non-infectious within one to two weeks—sometimes within days. That's quick enough to "turn off" transmission from a superspreader before they infect their entire network. The timeline matters enormously.
Beyond treatment, preventive therapy for people exposed to M. tuberculosis but not yet sick is highly effective. This creates a multi-layered toolkit: find the superspreading niches, identify the highly infectious individuals within them, treat them rapidly, and offer preventive therapy to their contacts. Each step disrupts transmission at a critical juncture.
The researchers acknowledge that superspreading remains poorly understood across infectious diseases broadly. Multiple factors collide—how infectious someone is, the size and structure of their social networks, broader epidemiological patterns—but exactly how these elements interact remains murky. Mathematical models hint, however, that preventing superspreading could have outsized impacts on disease transmission, potentially far exceeding what general prevention strategies achieve.
For tuberculosis, a disease that kills roughly 1.3 million people annually according to the World Health Organization, this shift in perspective could reshape global control efforts. Rather than viewing TB as a uniform transmission problem requiring uniform solutions, the superspreading niche framework invites a more nuanced approach: find the sharp points of transmission, disrupt them early, and let prevention cascade outward from there. In the global fight against TB, precision may be the missing lever.